Ticker
ABSICompany Name
ABSCI CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 0.21 | $ 173.37M | $ 36.52M |
3/31/2025 | 0.17 | $ 198.8M | $ 33.65M |
12/31/2024 | 0.19 | $ 179.13M | $ 34.48M |
9/30/2024 | 0.17 | $ 201.34M | $ 33.9M |
6/30/2024 | 0.15 | $ 221.49M | $ 34.04M |
3/31/2024 | 0.14 | $ 240.11M | $ 34.79M |
12/31/2023 | 0.23 | $ 176.18M | $ 41.12M |
9/30/2023 | 0.2 | $ 196.42M | $ 39.93M |
6/30/2023 | 0.18 | $ 215.4M | $ 38.75M |
3/31/2023 | 0.16 | $ 253.97M | $ 41.84M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Liabilities / Equity
(=) D/E
D/E for ABSCI CORP is calculated as follows: Liabilities [ $ 21.56M ] / Equity [ $ -89.43M ]
(=) D/E [ 0 ]
Minimum
Mar 31, 2024
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.03 |
average | 1.39 |
median | 0.98 |
std | 1.31 |